Revealing the immune cell subtype reconstitution profile in patients from the CLARITY study using deconvolution algorithms after cladribine tablets treatment by Irina Kalatskaya, Gavin Giovannoni, Thomas Leist, Joseph Cerra, Ursula Boschert, P. Alexander Rolfe

Get full text

Immunomodulatory Effects Associated with Cladribine Treatment by Nicolás Fissolo, Laura Calvo-Barreiro, Herena Eixarch, Ursula Boschert, Carmen Espejo, Xavier Montalban, Manuel Comabella

Get full text

EVOBRUTINIB TREATMENT REDUCES THE DAMAGE TO THE CNS AND INCREASES THE NUMBER OF CLASSICAL DENDRITIC CELLS IN EXPERIMENTAL MULTIPLE SCLEROSIS by Mari Paz Serrano-Regal, Leticia Calahorra, Inmaculada Alonso-García, Ursula Boschert, Philipp Haselmayer, María Cristina Ortega, Isabel Machin-Diaz, Celia Camacho-Toledano, Jennifer García-Arocha, Diego Clemente

Get full text

Molecular signature associated with cladribine treatment in patients with multiple sclerosis by Nicolas Fissolo, Laura Calvo-Barreiro, Herena Eixarch, Ursula Boschert, Luisa M. Villar, Lucienne Costa-Frossard, Mireia Ferrer, Alex Sanchez, Alex Sanchez, Eva Borràs, Eva Borràs, Eduard Sabidó, Eduard Sabidó, Carmen Espejo, Xavier Montalban, Manuel Comabella

Get full text

Human T-bet+ B cell development is associated with BTK activity and suppressed by evobrutinib by Liza Rijvers, Jamie van Langelaar, Laurens Bogers, Marie-José Melief, Steven C. Koetzier, Katelijn M. Blok, Annet F. Wierenga-Wolf, Helga E. de Vries, Jasper Rip, Odilia B.J. Corneth, Rudi W. Hendriks, Roland Grenningloh, Ursula Boschert, Joost Smolders, Marvin M. van Luijn

Get full text